玻璃体切除联合白内障手术治疗增生性糖尿病视网膜病变

The Clinical Effect of Vitrectomy Combined With Cataract Surgery for Proliferative Diabetic Retinopathy

目的比较单纯玻璃体切除手术与玻璃体切除联合白内障手术治疗增生性糖尿病视网膜病变临床疗效。方法选取2016年1月—2018年1月我院收治的增生性糖尿病视网膜病变患者83例作为研究对象。根据手术方式的不同,将其分成观察组(41例)和对照组(42例)。观察组行玻璃体切除联合白内障手术治疗,对照组患者仅行玻璃体切除手术。两组患者均于术后随访6个月~2年,比较其视网膜复位率、最佳矫正视力水平和随访期间并发症发生情况。结果观察组术后视网膜复位率和最佳矫正视力高于对照组,手术并发症发生率低于对照组,差异均具有统计学意义(P <0.05)。结论玻璃体切除联合白内障手术治疗增生性糖尿病视网膜病变可有效提高视网膜复位率和术后视力水平,减少并发症发生率。

Objective To compared the clinical effects for proliferative diabetic retinopathy patients with vitrectomy combined with cataract surgery. Methods 83 cases of patients with PDR from January 2016 to January 2018 were selected as the study objects. According to the different surgical methods, they were divided into the observation group （41 cases） and the control group （42 cases）. The observation group underwent vitrectomy combined with cataract surgery. The patients in the control group underwent vitrectomy only. The two groups were followed up for 6 months to 2 years. The retinal reattachment rate, best corrected visual acuity and complications during follow-up were compared. Results The rate of retinal reattachment and the best corrected visual acuity in the observation group were higher than those in the control group, and the incidence of operative complications was lower than that in the control group. The difference was statistically signifcant （P 〈 0.05）. Conclusion vitrectomy plus cataract surgery can improve vitrectomy plus cataract surgery with less complication for proliferative diabetic retinopathy.